Quick Summary
Indian Opinion Analysis
The growth of pharmaceutical compositions using microRNAs signifies evolution in precision medicine with potential global ramifications for healthcare. India, as a major player in generic drug production and biotechnology innovation, could benefit from adapting to this emerging field by fostering research and building partnerships with academic and industrial stakeholders globally. Prioritizing such initiatives may enhance india’s ability to lead advancements while ensuring accessibility and affordability for its population thru domestic adaptations of these technologies.